Shiseido
This article was originally published in The Rose Sheet
Executive Summary
Japanese firm expects to record $41.8 mil. (Y1=$.008) net loss for fiscal first half (ended Sept. 30), company announces as part of revised earnings forecast. Loss will reflect Shiseido's decision to remove products that do not meet Japan's new Pharmaceutical Affairs Law labeling requirements and replace them with updated labels ahead of deadline to avoid consumer confusion, firm says. Shiseido predicted net income of $25 mil. in May. Estimated first half net sales of $2.42 bil. will remain unchanged. For the year, Shiseido expects to record net loss of $75.2 mil. rather than income of $83.5 mil., while net sales expected to be $5.01 bil. remains unchanged